|1.||Ren-an, Qin: 1 article (10/2014)|
|2.||Chunyan, Huang: 1 article (10/2014)|
|3.||Chuyuan, Li: 1 article (10/2014)|
|4.||Wenjuan, Fu: 1 article (10/2014)|
|5.||Lin, Huang: 1 article (10/2014)|
|6.||Xuemei, Yu: 1 article (10/2014)|
|7.||Hong, Nie: 1 article (10/2014)|
|8.||Juan, Lin: 1 article (10/2014)|
|9.||Zhang, Keru: 1 article (08/2012)|
|10.||Meng, Lingkuo: 1 article (08/2012)|
|1.||Myocardial Ischemia (Ischemic Heart Diseases)
01/31/2012 - "Experiments were performed in rats treated with SME or vehicle, as well as in those treated with Fufang Danshen Tablet (FDT) as a positive control which has previously been shown to prevent myocardial ischemia. "
10/28/2014 - "Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia/reperfusion injury via the Akt-eNOS signaling pathway in rats."
08/01/2012 - "Salvianolic acid B (SAB), tanshinone IIA (TS), ginsenoside Rb₁ (Rb₁), ginsenoside Rg₁ (Rg₁) and notoginsenoside R₁ (R₁) are major active ingredients of Fufang Danshen preparation (FDP) for its protective effects on myocardial ischemia. "
|3.||Hypertension (High Blood Pressure)
02/01/2012 - "A randomized, double-blind, placebo-controlled study to evaluate the efficacy and tolerability of Fufang Danshen (Salvia miltiorrhiza) as add-on antihypertensive therapy in Taiwanese patients with uncontrolled hypertension."
02/01/2012 - "It was concluded that Fufang Danshen (Salvia miltiorrhiza) extract reduced systolic blood pressure and pulse rate, and was well tolerated in patients with hypertension."
02/01/2012 - "Fifty-five patients with uncontrolled mild to moderate hypertension were enrolled under current conventional antihypertensive treatment, randomized equally to receive a Fufang Danshen capsule (formula mixture) 1000 mg twice-daily or a placebo capsule for 12 weeks. "
11/01/2009 - "With Fufang Danshen Pill as positive control drug,the effects of Rhizoma Zingiberis and Pericarpium Citri Reticulatae extracts on the electrocardiogram (ECG), the extension of myocardial infarction, the hemorheology indexes, lactic dehydrogenase (LDH), creatine kinase (CK), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and malondialdehyde (MDA) in rats were evaluated. "
|1.||salvianolic acid B
|3.||formycin diphosphate (FDP)
|8.||Creatine Kinase (Creatine Phosphokinase)